IRIS

Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C).

Madia, V.N., Messore, A., Saccoliti, F., Tudino, V., De Leo, A., De Vita, D., et al. (2020). Tegaserod for the treatment of Irritable Bowel syndrome. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 19, 1-28 [10.2174/1871523018666190911121306].

Tegaserod for the treatment of Irritable Bowel syndrome

Tudino, Valeria;
2020-01-01

Abstract

Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C).
2020
Madia, V.N., Messore, A., Saccoliti, F., Tudino, V., De Leo, A., De Vita, D., et al. (2020). Tegaserod for the treatment of Irritable Bowel syndrome. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 19, 1-28 [10.2174/1871523018666190911121306].
1.1 Articolo in rivista
File in questo prodotto:
File Dimensione Formato  
Madia_Tegaserod_2019.pdf

non disponibili

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.41 MB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
1.41 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1282134